GlassScriptPhysician profile
April Janean Barbara
NPI 1336713270
$2,400.89
in general payments reported to CMS, 2019-2025
19 companies · $322 in 2025
The $322 reported for 2025 was more than what 90% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $55.06 · 2022: $449 · 2023: $611 · 2024: $963 · 2025: $322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,897.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,897.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $253.70 | 2022-2024 | Summit Doppler |
| Myriad Women'S Health, INC. | $250.47 | 2023 | Myrisk |
| Mayne Pharma Commercial LLC | $238.51 | 2024-2025 | |
| Abbvie INC. | $238.27 | 2021-2024 | |
| Astellas Pharma US INC | $238.22 | 2023-2024 | Veozah |
| Biogen, INC. | $227.99 | 2024-2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $135.59 | 2024 | Aptima |
| Organon LLC | $133.43 | 2022-2023 | Nexplanon |
| Ibsa Pharma INC. | $125.00 | 2024 | Tirosint |
| Evofem Biosciences, INC. | $120.70 | 2022 | |
| Novo Nordisk INC | $120.65 | 2024 | Wegovy |
| Sage Therapeutics, LLC | $100.16 | 2023 | |
| Exact Sciences Corporation | $60.35 | 2024 | Cologuard Collection Kit |
| Radiometer America, INC | $57.24 | 2025 | |
| Shield Therapeutics INC | $28.40 | 2023 | Accrufer |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $22.47 | 2024 | |
| Exeltis, USA INC. | $17.55 | 2021 | |
| Agile Therapeutics, INC. | $17.21 | 2021 | |
| Gynesonics, INC. | $14.98 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw April Barbara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.